Lilly - March 2026 - case study 1

Start date:

Optimising Intravenous (IV) Infusion, MRI, and Outpatient Pathways for Alzheimer's Disease (AD) Treatment

Last reviewed date: 01 April 2026

Next review date: 01 April 2029